Healthcare payments + RCM platform; NASDAQ: WAY; serial acquirer (Iodine $1.25B close 2025-10-01).
Anchor of the Op 1 acquirer-radar SKU. Canonical Supabase entity_id resolved to 741673 (verified against entities table on the burst cluster).
📍 San Antonio, Texas, USA
Closed Oct 1, 2025; Iodine integrated under Waystar's clinical-AI segment; founder and CFO retained through transition.
Advent International exits at $1.25B enterprise value after 4-year hold; Iodine becomes the clinical-AI anchor of Waystar's RCM platform.
Definitive agreement signed; Waystar confirmed total enterprise value of $1.25B, financing via existing revolver + new term loan B.
Briefings · Research · Memos for Waystar
Briefings
0None yet — draft one
Deep Research
Memos
0No synthesis memos linked.